Table 9.12b

Unadjusted Patient Survival, Living Donor Liver Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

  3 Months 1 Year 3 Years 5 Years
(Tx 2002 - 2003) (Tx 2002 - 2003) (Tx 2000 - 2003) (Tx 1998 - 2003)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 664 93.5% 1.0% 664 87.7% 1.3% 1,554 80.2% 1.1% 1,874 77.4% 1.2%
Primary Diagnosis Non-Cholestatic Cirrhosis 336 94.9% 1.2% 336 87.8% 1.8% 792 78.5% 1.6% 906 75.1% 1.8%
Cholestatic Liver Disease/Cirrhosis 136 96.3% 1.6% 136 94.1% 2.0% 280 89.2% 2.1% 308 87.0% 2.5%
Acute Hepatic Necrosis 33 81.8% 6.7% 33 72.7% 7.8% 78 70.0% 5.3% 104 70.9% 4.5%
Biliary Atresia 68 92.6% 3.2% 68 92.6% 3.2% 165 87.5% 2.6% 246 84.6% 2.6%
Metabolic Diseases 15 80.0% 10.3% 15 66.7% 12.2% 45 71.6% 7.1% 62 75.0% 5.6%
Malignant Neoplasms 28 89.3% 5.8% 28 71.4% 8.5% 85 64.6% 5.5% 109 57.7% 5.3%
Other 47 91.5% 4.1% 47 87.2% 4.9% 108 83.4% 3.8% 138 80.6% 3.7%
Unknown 1 100.0% 0.0% 1 100.0% 0.0% 1 + + 1 + +


Source: OPTN/SRTR Data as of May 2, 2005.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death.Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on liver transplants.

Multi-organ transplants are excluded.